EBV and Autoimmunity
- 4 July 2025
- book chapter
- Published by Springer Nature
- p. 1-27
Abstract
Although the role of Epstein-Barr virus (EBV) in autoimmunity is biologically plausible and evidence of altered immune responses to EBV is abundant in several autoimmune diseases, inference on causality requires the determination that disease risk is higher in individuals infected with EBV than in those uninfected and that in the latter it increases following EBV infection. This determination has so far been obtained compellingly for multiple sclerosis (MS) and, to some extent, for systemic lupus erythematosus (SLE). In contrast, evidence is either lacking or not supportive for other autoimmune conditions. In this chapter, we present the main epidemiological findings that justify these conclusions and their implications for prevention and treatment.Keywords
This publication has 147 references indexed in Scilit:
- Race, Ethnicity, and Disparities in the Risk of End‐Organ Lupus Manifestations Following a Systemic Lupus Erythematosus Diagnosis in a Multiethnic CohortArthritis Care & Research, 2022
- Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance ProjectArthritis Care & Research, 2020
- Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple SclerosisJAMA Neurology, 2020
- Role of the HLA System in the Association Between Multiple Sclerosis and Infectious MononucleosisArchives of Neurology, 2011
- Multiple Sclerosis After Infectious MononucleosisArchives of Neurology, 2007
- Epstein-Barr Virus and Multiple SclerosisArchives of Neurology, 2006
- Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysisAnnals of Neurology, 2006
- Epstein-Barr Virus Antibodies and Risk of Multiple SclerosisJAMA, 2001
- Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelinationAnnals of Neurology, 2000
- Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagersArthritis & Rheumatism, 1999